Literature DB >> 28193706

Small Vessels, Big Role: Renal Microcirculation and Progression of Renal Injury.

Alejandro R Chade1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28193706      PMCID: PMC5344725          DOI: 10.1161/HYPERTENSIONAHA.116.08319

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  142 in total

Review 1.  Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.

Authors:  Lauren M Willis; Azza B El-Remessy; Payaningal R Somanath; David L Deremer; Susan C Fagan
Journal:  Clin Sci (Lond)       Date:  2011-04       Impact factor: 6.124

2.  Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

Authors:  T D Henry; K Rocha-Singh; J M Isner; D J Kereiakes; F J Giordano; M Simons; D W Losordo; R C Hendel; R O Bonow; S M Eppler; T F Zioncheck; E B Holmgren; E R McCluskey
Journal:  Am Heart J       Date:  2001-11       Impact factor: 4.749

3.  VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts.

Authors:  Toshihiro Shimizu; Hiroshi Okamoto; Satoru Chiba; Yutaka Matsui; Takeshi Sugawara; Masatoshi Akino; Jia Nan; Hideki Kumamoto; Hisao Onozuka; Taisei Mikami; Akira Kitabatake
Journal:  Cardiovasc Res       Date:  2003-04-01       Impact factor: 10.787

Review 4.  The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function.

Authors:  D P Basile
Journal:  Kidney Int       Date:  2007-05-02       Impact factor: 10.612

5.  GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways.

Authors:  Konstantinos N Aronis; John P Chamberland; Christos S Mantzoros
Journal:  Metabolism       Date:  2013-05-14       Impact factor: 8.694

6.  Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs.

Authors:  Alejandro R Chade; Michael D Bentley; Xiangyang Zhu; Martin Rodriguez-Porcel; Sara Niemeyer; Beatriz Amores-Arriaga; Claudio Napoli; Erik L Ritman; Amir Lerman; Lilach O Lerman
Journal:  J Am Soc Nephrol       Date:  2004-07       Impact factor: 10.121

7.  Sitagliptin therapy enhances the number of circulating angiogenic cells and angiogenesis-evaluations in vitro and in the rat critical limb ischemia model.

Authors:  Sarah Chua; Jiunn-Jye Sheu; Yung-Lung Chen; Li-Teh Chang; Cheuk-Kwan Sun; Steve Leu; Hsin-Ching Sung; Tzu-Hsien Tsai; Sheng-Ying Chung; Kuo-Ho Yeh; Chung-Lung Cho; Ying-Hsien Kao; Hon-Kan Yip
Journal:  Cytotherapy       Date:  2013-07-10       Impact factor: 5.414

8.  Antioxidant intervention blunts renal injury in experimental renovascular disease.

Authors:  Alejandro R Chade; Martin Rodriguez-Porcel; Joerg Herrmann; Xiangyang Zhu; Joseph P Grande; Claudio Napoli; Amir Lerman; Lilach O Lerman
Journal:  J Am Soc Nephrol       Date:  2004-04       Impact factor: 10.121

9.  Disparate effects of single endothelin-A and -B receptor blocker therapy on the progression of renal injury in advanced renovascular disease.

Authors:  Alejandro R Chade; Nicholas J Stewart; Patrick R Peavy
Journal:  Kidney Int       Date:  2013-12-18       Impact factor: 10.612

Review 10.  The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda.

Authors:  Danilo Fliser; Andrzej Wiecek; Gultekin Suleymanlar; Alberto Ortiz; Ziad Massy; Bengt Lindholm; Alberto Martinez-Castelao; Rajiv Agarwal; Kitty J Jager; Friedo W Dekker; Peter J Blankestijn; David Goldsmith; Adrian Covic; Gerard London; Carmine Zoccali
Journal:  Kidney Int Suppl (2011)       Date:  2011-06
View more
  7 in total

Review 1.  Targeting angiogenesis and lymphangiogenesis in kidney disease.

Authors:  Katsuyuki Tanabe; Jun Wada; Yasufumi Sato
Journal:  Nat Rev Nephrol       Date:  2020-03-06       Impact factor: 28.314

Review 2.  Understanding and managing atherosclerotic renovascular disease: still a work in progress.

Authors:  Alejandro R Chade
Journal:  F1000Res       Date:  2018-11-29

3.  High-fat diet-induced kidney alterations in rats with metabolic syndrome: endothelial dysfunction and decreased antioxidant defense.

Authors:  Raquel Rangel Silvares; Evelyn Nunes Goulart da Silva Pereira; Edgar Eduardo Ilaquita Flores; Karine Lino Rodrigues; Adriana Ribeiro Silva; Cassiano Felipe Gonçalves-de-Albuquerque; Anissa Daliry
Journal:  Diabetes Metab Syndr Obes       Date:  2019-09-06       Impact factor: 3.168

4.  Assessing Renal Microvascular Reactivity by Laser Speckle-Contrast Imaging in Angiotensin-II-Treated Mice.

Authors:  Nicolas Mottard; Dan E Berkowitz; Lakshmi Santhanam
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-03-27

Review 5.  Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases.

Authors:  Yuling Huang; Lina Yang
Journal:  Stem Cell Res Ther       Date:  2021-03-31       Impact factor: 6.832

Review 6.  Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease.

Authors:  William B Horton; Eugene J Barrett
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

Review 7.  Imaging the Renal Microcirculation in Cell Therapy.

Authors:  Katerina Apelt; Roel Bijkerk; Franck Lebrin; Ton J Rabelink
Journal:  Cells       Date:  2021-05-02       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.